A damage/benefit evaluation of addictive products use

Saved in:

Bibliographic Details
Main Author:	Bourgain, C.
Other Authors:	ET AL
Format:	Journal Article
Language:	English
Subjects:	Actitudes Beneficios Detección Drogas ilegales Drogas legales Drogodependencias Efectos Enfermedad Evaluación Francia Impacto social Riesgo Salud Adicciones Documental
Online Access:	DOI Path
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items: A damage/benefit evaluation of addictive products use

Quick Look
A damage/benefit evaluation of addictive products use
Quick Look
Population, professional and client views on the dangerousness of addictions: testing the familiarity hypothesis
Quick Look
THE OTHER HEALTH BENEFITS OF MODERATE ALCOHOL INTAKE
Quick Look
THE BENEFIT OF ALCOHOL IN MODERATION
Quick Look
Estimating the harms of nicotine containing products using the MCDA approach
Quick Look
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Quick Look
4-Methylamphetamine (4-MA). Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances
Quick Look
5-(2-Aminopropyl)indole (5-IT). Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances
Quick Look
COSTS AND BENEFITS OF TREATMENT FOR COCAINE ADDICTION IN DATOS
Quick Look
MEASURING THE HARM FROM ILLEGAL DRUG USING THE DRUG HARM INDEX
Quick Look
ARE THERE NET HEALTH BENEFITS FROM MODERATE ALCOHOL CONSUMPTION? MORBIDITY AND OTHER PARAMETERS OF HEALTH
Quick Look
Addiction surplus: The add-on margin that makes addictive consumptions difficult to contain
Quick Look
Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population
Quick Look
ALCOHOL: HEALTH BENEFITS CHALLENGED...
Quick Look
Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits
Quick Look
THE FINANCIAL COSTS AND BENEFITS OF ALCOHOL
Quick Look
Consumer preference and perception of specific categories of tobacco and related products
Quick Look
COSTS AND BENEFITS OF A COMMUNITY SOBRIETY CHECKPOINT PROGRAM
Quick Look
Associations of recreational cannabis dispensaries’ availability, storefront signage and health benefit signs with cannabis use: findings from a representative adult sample in California, United States
Quick Look
EMCDDA-Europol Joint Report on a new psychoactive substance: 25I-NBOMe (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine)
Quick Look
EMCDDA-Europol Joint Report on a new psychoactive substance: AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide)
Quick Look
EMCDDA-Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)
Quick Look
EMCDDA-Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)
Quick Look
Harm from others’ drinking: How problematic do people with and without experience of harm perceive it to be?